ML22145A551
| ML22145A551 | |
| Person / Time | |
|---|---|
| Issue date: | 07/25/2022 |
| From: | Kevin Williams NRC/NMSS/DMSST |
| To: | Tallman M American Osteopathic Board of Radiology |
| J. Fisher, NMSS/MSST | |
| References | |
| Download: ML22145A551 (3) | |
Text
July 25, 2022 American Osteopathic Board of Radiology ATTN: Mary Cameron Tallman Senior Director 142 East Ontario Street Chicago, IL 60611-2864
SUBJECT:
AMERICAN OSTEOPATHIC BOARD OF RADIOLOGY, COMPLETION OF THE REVIEW FOR CONTINUED RECOGNITION BY THE U.S. NUCLEAR REGULATORY COMMISSION
Dear Mary Cameron Tallman:
Thank you for responding to the U.S. Nuclear Regulatory Commissions (NRC) letter dated March 15, 2022 (Agencywide Documents Access Management System (ADAMS)1 Accession No. ML22069A713), which requested confirmation that the American Osteopathic Board of Radiology (AOBR) continues to satisfy the NRC recognition criteria for specialty board certification processes in Title 10 of the Code of Federal Regulations (10 CFR) Part 352, Medical Use of Byproduct Material. The NRC staff reviewed your response letter dated April 12, 2022 (ML22102A319).
The NRC staff performed a review of each NRC-recognized specialty board per the Office of Nuclear Material Safety and Safeguards (NMSS) Office Procedure MSST-70-3, Procedures for Recognizing, Monitoring, and Terminating the Certification Process of Specialty Boards, Section 3.11, Monitoring Continued Satisfaction of Recognition Requirements (ML20351A389). As part of the review, the NRC staff evaluated the AOBRs publicly available website at https://certification.osteopathic.org/radiology/, as well as any provided documentation for changes that could affect the recognition of the boards certification processes. Based on your response letter and the NRCs subsequent review, the NRC staff determined that the following specialty areas continue to satisfy the board recognition criteria.
The Diagnostic Radiology specialty area continues to satisfy the board recognition criteria in 10 CFR 35.290, "Training for imaging and localization studies," 10 CFR 35.392, "Training for the oral administration of sodium iodide I-131 requiring a written directive in quantities less than or equal to 1.22 gigabecquerels (33 millicuries)," and 10 CFR 35.394, "Training for the oral administration of sodium iodide I-131 requiring a written directive in quantities greater than 1.22 gigabecquerels (33 millicuries)."
1 Records are available electronically for public inspection in the NRC Public Document Room or in the NRCs ADAMS, accessible from the NRC website at http://www.nrc.gov/reading-rm/adams.html.
2 The 10 CFR Part 35 index is available for review at:
https://www.govinfo.gov/app/collection/cfr/2021/title10/chapterI/part35.
M. Tallman The Radiation Oncology specialty area continues to satisfy the board recognition criteria in 10 CFR 35.390, "Training for use of unsealed byproduct material for which a written directive is required," 10 CFR 35.490, "Training for use of manual brachytherapy sources," and 10 CFR 35.690, "Training for use of remote afterloader units, teletherapy units, and gamma stereotactic radiosurgery units."
In addition, thank you for providing two new Diagnostic Radiology certificates, effective
- 1) May 12, 2017, to September 19, 2018, and 2) September 20, 2018, to present and two new Radiation Oncology certificates, effective 1) May 12, 2017, to September 19, 2018, and 2)
September 20, 2018, to present. The NRC staff added the certificates to the NRC public website titled Specialty Board(s) Certification Recognized by NRC Under 10 CFR Part 35, available at https://www.nrc.gov/materials/miau/med-use-toolkit/spec-board-cert.html. The NRC public website is used by NRC license reviewers, as well as license reviewers in Agreement States, to verify that the certificates submitted by licensees are valid. Please ensure that AOBR shares any future changes to certificates with the NRC with the date that the revised certificates became or will become effective.
In 2019, the NRC revised its medical use regulations, including training and experience requirements. A history of the rulemaking, pertinent guidance document references, and a summary of major changes are available in a 2018 presentation titled Final Rule - Medical Use Regulations in 10 CFR 30, 32, and 35 (ML19085A550).3 The NRC staff determined that AOBR is in compliance, but we encourage you to review these changes if you have not done so already.
This letter further confirms that as the Senior Director of the AOBR, you are the designee for all official correspondence with the NRC. If this changes in the future, please contact the NRC with the individual responsible for this role.
Please notify the NRC, via letter, if the board changes the boards name, certification processes, or certification documents because these changes could affect the recognition of certification process under the NRC requirements. In addition, please notify the NRC 6 months in advance of any plans for AOBR to become inactive or disband the Diagnostic Radiology or Radiation Oncology certification programs.
For further information or for questions, please contact Maryann Ayoade at (301) 415-0862 or via email at Maryann.Ayoade@nrc.gov or Jennifer Fisher at (301) 415-1456 or via email at Jennifer.Fisher@nrc.gov.
Clark, Theresa signing on behalf of Williams, Kevin on 07/25/22 Kevin Williams, Director Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguards 3 Additional information can be found in the July 16, 2018, section of the NRC website titled Background Information for Medical Licensees, available at https://www.nrc.gov/materials/miau/med-use-toolkit/background-info-med-license.html#july162018.
ML22145A551 OFFICE NMSS/MSST NMSS/MSST NMSS/MSST NMSS/MSST NMSS/MSST NAME J Fisher M Ayoade C Valentin-Rodriguez C Einberg K Williams DATE 07/14/2022 07/20/2022 07/21/2022 07/21/2022 07/25/2022